Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva pharmaceutical industries hi-res stock photography and images - Alamy
FDA approves Teva's generic EpiPen after yearslong delay
Teva Releases Generic EpiPen in Limited Doses in the U.S. - WSJ
Teva Pharmaceuticals: Key Facts And Trends Of 2015-2016 (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals to slash 14,000 jobs and suspend its dividend
Teva Pharmaceuticals Q4 2016 Earnings
News Update: Teva (NASDAQ: TEVA) Pharma Wins Race to Acquire Ratiopharm - YouTube
Teva Raises $2.1 Billion in Debt Tender Offer | Ctech
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
Teva claws back $50M from former execs, board members to pay for 2016 foreign bribery settlement | Fierce Pharma
October 2016 TEVA eNews | Total Equine Veterinary Associates
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva Pharmaceuticals to Buy Allergan's Generics Business - The New York Times
Teva Pharmaceuticals: Key Facts And Trends Of 2015-2016 (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical: Past Behind And A Promising 2023 (NYSE:TEVA) | Seeking Alpha
4 Factors That Sent Teva Pharmaceutical Industries Ltd. Sliding 45% in 2016 | The Motley Fool
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Pharmaceuticals: Key Facts And Trends Of 2015-2016 (NYSE:TEVA) | Seeking Alpha
Teva walks away from PhRMA after similar move by AbbVie
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Teva Pharmaceuticals will pay $420 million in a federal case
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
